Failure due to formal reasons within German benefit assessment of medicinal products: the dilemma between marketing authorization and HTA
| Image |  |
|---|---|
| Description | scientific article published on 20 February 2020 |
| Author/s |
author: Charalabos-Markos Dintsios |
| Publication date | February 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |